the vaccine – Page 42 – Communicable Diseases Research

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

브라질에서 코로나 박 코비드 -19 백신의 이전 수용자 (RHH-001)의 이전 수용자에서 이종과 동종 코비드 -19 부스터 백신 접종

Clinical Trial

Published on 2022-02-052022-08-13
Journal: Lancet (London, England) [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 임상, 진단, 치료기술,

Design of a multi-epitope-based peptide vaccine against the S and N proteins of SARS-COV-2 using immunoinformatics approach

Research

Published on 2022-02-042022-11-01
Journal: The Egyptian Journal of Medical Human Genetics [Category] COVID-19,

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies

불활성화 백신의 동종 또는 이종 부스터는 중화 항체로부터 SARS-CoV-2 오미크론 변이체 탈출을 감소시킵니다.

Coronaviruses

Published on 2022-02-042022-09-10
Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단,

[키워드] accumulated addition antibodies Antibody titer B.1.1.529 BBIBP-CorV booster booster vaccination convalescent dose eight epitope Epitopes Heterologous homologous homologous or heterologous identified variant inactivated Inactivated vaccine individual less mAb mAbs monoclonal antibodies monoclonal antibody neutralization neutralization titer neutralization titers Neutralizing neutralizing antibody Neutralizing antibody titer NTD omicron Omicron variant protein subunit vaccine pseudovirus raising RBD reduce reduction SARS-CoV-2 SARS-CoV-2 variants sera Seven significantly increased spike mutations Subunit vaccine tested the vaccine therapeutic therapeutic antibodies transmission of SARS-CoV-2 urgency Vaccine variant Viral viral variant VOCs ZF2001
[DOI] 10.1080/22221751.2022.2030200 PMC 바로가기 [Article Type] Coronaviruses

Predicting the COVID-19 vaccine receive intention based on the theory of reasoned action in the south of Iran

Research

Published on 2022-02-042022-10-28
Journal: BMC Public Health [Category] COVID-19, COVID19(2023년), Fulltext, MERS, SARS,

Acceptance rate and risk perception towards the COVID-19 vaccine in Botswana

Research Article

Published on 2022-02-042022-10-28
Journal: PLoS ONE [Category] COVID-19, COVID19(2023년), MERS, SARS,

SARS-CoV-2 Omicron variant in cancer patients: an insight into the vaccine booster debate

암 환자의 SARS-CoV-2 오미크론 변이체: 백신 부스터 논쟁에 대한 통찰력

Editorial

Published on 2022-02-032022-09-10
Journal: Future Oncology [Category] COVID19(2023년), MERS, SARS, 변종,

[키워드] booster Cancer omicron SARS-CoV-2 the vaccine variant
[DOI] 10.2217/fon-2022-0024 PMC 바로가기 [Article Type] Editorial

Predictors of uncertainty and unwillingness to receive the COVID-19 booster vaccine: An observational study of 22,139 fully vaccinated adults in the UK

Articles

Published on 2022-02-032022-10-30
Journal: The Lancet Regional Health - Europe [Category] COVID-19,

[키워드] addition administration Adults affected age approved booster booster vaccination Booster vaccine booster vaccines Compliance concerning COVID-19 Covid-19 social study COVID-19 vaccination programme COVID-19 vaccine Critical Evidence examined Factor Factors finding FIVE foundation funding Government groups health condition Health messaging highlight identifying infected with COVID-19 initial Innovation Intention lockdowns Logistic regression network physical poor compliance predict predictor Public receive receiving reported risk second socio-demographic Spread Stress supported the vaccine UCL used data Vaccine hesitancy vaccine refusal virus Wellcome Trust widespread with COVID-19
[DOI] 10.1016/j.lanepe.2022.100317 PMC 바로가기 [Article Type] Articles

Comparison of Anti-SARS-CoV-2 S1 Receptor-Binding Domain Antibody Immunoassays in Health Care Workers Before and After the BNT162b2 mRNA Vaccine

BNT162b2 mRNA 백신 전과 후 의료 종사자의 Anti-SARS-CoV-2 S1 수용체 결합 도메인 항체 면역 측정법의 비교

Article

Published on 2022-02-032022-09-11
Journal: American journal of clinical pathology [Category] COVID19(2023년), SARS, 치료기술, 치료법,

[키워드] 2019-nCoV anti-RBD antibody antibody concentration antibody production assays biomedical engineering blood sample Blood samples BNT162b2 BNT162b2 mRNA BNT162b2 vaccine booster dose Care collected COVID-19 DiaSorin dose Elecsy Elecsys Engineering evaluated Health Health care IgG immunoassay immunoassays Immunoglobulin Immunoglobulin G induce interquartile range LIAISON median medians New nucleocapsid protein Nucleocapsid proteins Pfizer Pfizer-BioNTech professional RBD Receptor-binding domain Roche Roche Diagnostics S-RBD SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection Siemens Healthineers Snibe Diagnostics spike glycoprotein statistically significant tested the median the receptor-binding domain the vaccine Type of antibody U/mL vaccination Vaccine were measured worker
[DOI] 10.1093/ajcp/aqab107 PMC 바로가기 [Article Type] Article

Incidence, Pattern and Severity of Adverse Events Following Immunization (AEFIs) Associated With Chadox1 nCOV-19 Corona Virus Vaccine (Recombinant) Among the Healthcare Workers of a Tertiary Care Institute of Eastern Uttar Pradesh, India

Infectious Disease

Published on 2022-02-022022-10-31
Journal: Cureus [Category] COVID-19,

COVID-19 Vaccine Refusal among Nurses Worldwide: Review of Trends and Predictors

Brief Report

Published on 2022-02-022022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] 95% CI Community conducted coronavirus country COVID-19 COVID-19 vaccination COVID-19 vaccine Factor Final flu vaccination healthcare Healthcare system lack Male sex media Nurse Nurses Older age Patient Perception predictor Prevalence recent refusal review Side effects the vaccine trend vaccination Vaccine Vaccines
[DOI] 10.3390/vaccines10020230 PMC 바로가기 [Article Type] Brief Report